NYLI WMC International Research Equity Fund LSE:AZN Holdings History
NYLI WMC International Research Equity Fund's AstraZeneca PLC Holding Summary
As of 2025-04-30, NYLI WMC International Research Equity Fund held 16,153.00 shares of AstraZeneca PLC(LSE:AZN), totaling £2.31 Mil. This investment constitutes 1.14% of their stock portfolio, and NYLI WMC International Research Equity Fund now holds 0% of the outstanding AstraZeneca PLC(LSE:AZN) stock.
The initial trade took place in 2021Q4. And since then NYLI WMC International Research Equity Fund has made 7 purchases of LSE:AZN, at an average price of £94.50, for a total of 35,807.00 shares. In addition, there have been 7 sales at an average price of £105.44 for 19,654.00 shares. Based on historical transaction data and LSE:AZN's current price of £102.94, NYLI WMC International Research Equity Fund's estimated gain on his LSE:AZN holdings is £351,193.74, reflecting a 10.38% gain to date.
NYLI WMC International Research Equity Fund LSE:AZN (£102.94) Holding Chart
NYLI WMC International Research Equity Fund LSE:AZN (£102.94) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price £-/Share | ||
Shares Sold | 0 | Average Price £-/Share | ||
Current Price £0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1